Post Holdings, Gilead Sciences fall; Pfizer, Hibbett rise

NEW YORK (AP) — Stocks that moved heavily or traded substantially Friday: Pfizer Inc., up 51 cents to $36.70. The drug developer is asking U.S. regulators to allow ...

Health experts clash over use of certain drugs for COVID-19

Health officials around the world are clashing over the use of certain drugs for COVID-19, leading to different treatment options for patients depending on where they live. On Friday...

Unwelcome milestone: California nears million COVID-19 cases

LOS ANGELES (AP) — A month ago, Antonio Gomez III was a healthy 46-year-old struggling like so many others to balance work and parenting during the coronavirus pandemic. This week, ...

Doctors may be better equipped to handle latest virus surge

NEW YORK (AP) — The latest surge in U.S. coronavirus cases appears to be much larger than the two previous ones, and it is all but certain to get worse — a lot worse. But experts say there are also re...

US allows 1st emergency use of a COVID-19 antibody drug

U.S. health officials have allowed emergency use of the first antibody-drug to help the immune system fight COVID-19, an experimental approach against the virus that has killed more than 238,000 Ameri...

Public health may be US election loser as coronavirus surges

Regardless of the presidential election outcome, a vexing issue remains to be decided: Will the U.S. be able to tame a perilous pandemic that is surging as holidays, winter and other challenges approa...

Expect a lot more of the same if Trump wins a second term

Expect to see a lot more of the same if there's a second Trump administration. President Donald Trump has consistently pointed to tax cuts and regulatory relief as key successes of h...

Expect a lot more of the same if Trump wins a second term

Expect to see a lot more of the same if there's a second Trump administration. President Donald Trump has consistently pointed to tax cuts and regulatory relief as key successes of h...

Expect a lot more of the same if Trump wins a second term

Expect to see a lot more of the same if there's a second Trump administration. President Donald Trump has consistently pointed to tax cuts and regulatory relief as key successes of h...

Editorial Roundup: US

Excerpts from recent editorials in the United States and abroad: ___ Oct. 27 The Los Angeles Times on the Dodgers' World Series win: ...

Mexican border state of Chihuahua returns to lockdown

MEXICO CITY (AP) — Mexico’s northern border state of Chihuahua returned to the highest level of alert and lockdown Friday after coronavirus cases jumped there and hospitals began to fill up. ...

Intel, American Express fall; Mattel, Boston Beer rise

NEW YORK (AP) — Stocks that moved heavily or traded substantially Friday: Gilead Sciences Inc., up 12 cents to $60.79. Regulators approved the company's antiviral m...

The Latest: New cases in India below 60,000 for 5th day

NEW DELHI — India has reported below 60,000 new coronavirus cases for a fifth day as the promise of a free COVID-19 vaccine turned into a key state election issue. The Health Ministr...

US FDA approves first COVID-19 drug: the antiviral remdesivir

The U.S. Food and Drug Administration has approved the first drug to treat COVID-19: remdesivir, an antiviral medicine given through an IV for patients needing hospitalization. The drug, which Cali...

FDA approves remdesivir, the first drug for treating COVID-19.

WASHINGTON (AP) — FDA approves remdesivir, the first drug for treating COVID-19.